Protocol Information

If you are interested in learning more about this study, please call or email the contact person below

Title A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes (D5551C00002)
Description Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

This study will be in downtown Buffalo
Objective The study examines the Safety and efficacy study of exenatide once weekly in children and adolescents with type 2 diabetes.

keywords: type II, pediatrics
Principal Investigator MASTRANDREA, LUCY
Age Group Children
Drugs Involved
Clinical Trials.gov http://www.clinicaltrials.gov/ct2/show/NCT01554618/
Status Open
Key Eligibility Ages 10-17
Type 2 Diabetes
Disease Group Children's Health/Pediatrics; Diabetes; Endocrine Diseases
Treatment Exenatide
Contact AMANDA AYLER (HOUSE)
716-878-7588
ajayler@buffalo.edu